|
|
|
31.07.26 - 16:15
|
Moderna: Modest Gains (TradingView)
|
|
|
Moderna shares traded mostly sideways over the past week, but today we're seeing renewed upward movement. Our primary view remains that MRNA is likely to see further declines in the near term. After a low well above support at $22.32, however, a recovery should unfold, pushing the stock up to and above resistance at $85.60. If the stock were to fall below support at $22.32 in the near future, we would expect to see a lower low before the anticipated upward move resumes (probability: 20%).
|
|
|
10.07.26 - 13:18
|
Another Opportunity, The Same Process in MRNA (TradingView)
|
|
|
https://www.tradingview.com/x/gmayCOKe/
After entering **PANW**, I continued monitoring several other stocks that had already caught my attention. A number of them were demonstrating strong relative strength and, from my perspective, signs of sustained institutional participation.
Among those names, **MRNA** was the next asset to present a valid entry according to my trading plan. The signal appeared very close to the market close, and my order was filled in the final minutes of the session.
Because of the timing, I didn't have the opportunity to reduce the trade's risk by moving my stop-loss to **break-even** before the market closed.
As I write this before today's opening, MRNA is trading **higher in the pre-market**. I don't interpret that as a prediction of what will happen next, nor do I assume the trade will become profitable because of it.
What matters to me is much simpler.
If the opening provides enough strength, I'll have the opportunity to move my stop-loss to **break-even**, making the posi
|
|
|
|
|
11.05.26 - 10:30
|
Moderna im Hantavirus-Fieber! (Ariva)
|
|
|
Ein lokaler Ausbruch des Hantavirus auf einem Kreuzfahrtschiff treibt die Moderna-Aktie (MRNA) an. https://traderzeitung.de/boerse/hot-news/moderna-im-hantavirus-fieber-zwischen-spekulativem-kurssprung-und-hart-167994.html -micha1
|
|
|
08.05.26 - 21:27
|
ad-hoc-news.: Aktie im Aufwind (Ariva)
|
|
|
Moderna Inc Aktie (US60770K1079): Quartalsumsatz deutlich über Guidance, Aktie im AufwindDie Aktie von Moderna Inc (ISIN: US60770K1079, Ticker: MRNA) notiert am 08.05.2026 auf dem US-amerikanischen Markt bei rund 48,70 US-Dollar ... -micha1
|
|
|
08.05.26 - 21:18
|
Hantavirus Schlagzeilen treiben Impfstoff Aktie an (Ariva)
|
|
|
Medienberichten zufolge arbeitet Moderna seit dem September 2023 mit der Korea University an einem Hantavirus-Impfstoff. Laut The Hill befindet sich die Forschung noch in einem frühen Stadium. "Moderna hat in Zusammenarbeit mit dem U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) präklinische Forschungen zu Hantaviren durchgeführt, was die anhaltenden regionalen Auswirkungen dieser Krankheitserreger widerspiegelt“, zitiert die US-amerikanische Zeitung einen Unternehmenssprecher.https://de.investing.com/news/stock-market-news/hantavirusforschung-treibt-modernaaktie-um-16--an-93CH-3472484 -micha1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
22.01.26 - 17:45
|
Target PROFIT Reached (TradingView)
|
|
|
i published this setup on 15.1.26, before this break, we reached the target and even more, 43%
since i published it 11 days ago.
SUCCEEDED
congrats who took it.
I would place a stop on ATR or consider taking profit for now
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
